Refractory leg ulcers in prolidase deficiency with antiphospholipid antibody positivity responding to aspirin-hydroxychloroquine-vitamin C combination therapy

Dermatol Ther. 2020 Nov;33(6):e14156. doi: 10.1111/dth.14156. Epub 2020 Sep 14.

Authors

Muhammed Razmi T¹, Ankur Kumar Jindal², Kanika Arora², Vibhu Joshi², Deepti Suri², Dipankar De³

Affiliations

¹ Department Dermatology, IQRAA International Hospital and Research Centre, Calicut, India.
² Allergy Immunology Unit, Departments of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
³ Department of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

PMID: 32927500
DOI: 10.1111/dth.14156

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Antiphospholipid
Ascorbic Acid
Aspirin / adverse effects
Humans
Hydroxychloroquine
Leg Ulcer* / diagnosis
Leg Ulcer* / drug therapy
Leg Ulcer* / etiology
Prolidase Deficiency*

Substances

Antibodies, Antiphospholipid
Hydroxychloroquine
Ascorbic Acid
Aspirin